Abstract
A series of highly potent and specific fibrinogen receptor antagonists have been discovered and optimized through structural modification of the novel amidinoindole and benzofuran compounds, I and II. Systematic linker optimization afforded the amidinobenzofuran-containing inhibitor 29, which displayed an IC50 value of 250 nM in platelet aggregation assays. Attempts to enhance activity by modification of the beta-position of the beta-alanyl carboxylate group of 29 had only a modest effect on inhibitory activity in aggregation assays. Analogues prepared to enhance the activity by conformational restriction were also found to be equally or less potent. In contrast, modification at the alpha-position of the beta-alanyl carboxylate group resulted in the identification of extremely potent and novel amidinobenzofuran-containing derivatives 46-49. Reexamination of 5,6-bicyclic aromatic nucleus led to the further identification of amidinoindole- and amidinoindazole-containing derivatives 53-55. These analogues, 46-49 and 53-55, exhibited potent in vitro activity with IC50 values of 25-65 nM in platelet aggregation assays and an IC50 value of 2 nM in fibrinogen binding assays and demonstrated a selectivity of > 50,000-fold for GPIIb-III...Continue Reading
References
Nov 1, 1979·The Journal of Clinical Investigation·J S Bennett, G Vilaire
Nov 13, 1992·Journal of Medicinal Chemistry·L AligT Weller
Dec 25, 1992·Journal of Medicinal Chemistry·J A ZablockiL Feigen
Dec 1, 1990·The Journal of Cell Biology·I F CharoD A Cheresh
Jan 1, 1990·Annual Review of Cell Biology·N Kieffer, D R Phillips
Feb 1, 1988·Journal of Medicinal Chemistry·J AlexanderH Schwam
Jun 23, 1995·Journal of Medicinal Chemistry·J A ZablockiR J Lindmark
May 1, 1995·Bioorganic & Medicinal Chemistry·J A ZablockiR J Lindmark
Aug 18, 1995·Journal of Medicinal Chemistry·M E DugganJ J Lynch
Nov 11, 1994·Journal of Medicinal Chemistry·C D EldredK J Smith
Aug 5, 1994·Journal of Medicinal Chemistry·M S EgbertsonP D Manno
Jun 25, 1993·Journal of Medicinal Chemistry·J A ZablockiB B Taite
Nov 8, 1996·Journal of Medicinal Chemistry·J H HutchinsonG D Hartman
Citations
Jul 25, 2000·European Journal of Medicinal Chemistry·S OnoN Nakamura
Jun 8, 2001·Bioorganic & Medicinal Chemistry Letters·A PandeyR M Scarborough
Aug 31, 2001·Bioorganic & Medicinal Chemistry Letters·T SuB Y Zhu
Oct 26, 2001·Bioorganic & Medicinal Chemistry Letters·T SuB Y Zhu
Mar 23, 2002·Bioorganic & Medicinal Chemistry Letters·Mukund M MehrotraRobert M Scarborough
Jul 31, 1999·Bioorganic & Medicinal Chemistry·K AlexopoulosJ Matsoukas
Jul 9, 2013·Journal of Medicinal Chemistry·Radoslaw LauferHenry W Pauls
Dec 22, 2007·BMC Molecular Biology·Susanta PahariR Manjunatha Kini
Apr 1, 2010·BMC Genomics·Juliana Alves-SilvaMichael J Lehane
Nov 16, 2010·Toxicon : Official Journal of the International Society on Toxinology·Maisa Splendore Della-CasaAna Maria Moura-da-Silva
Aug 2, 2011·Toxicon : Official Journal of the International Society on Toxinology·Erin M Walsh, Cezary Marcinkiewicz
Aug 19, 2007·Chemistry : a European Journal·Hao JiangKarl Anker Jørgensen
Mar 13, 2003·Chemical Reviews·Douglas A HortonMark L Smythe
Oct 16, 2012·The Journal of Organic Chemistry·Shashi PandeyPrem M S Chauhan
Mar 16, 2002·The Journal of Organic Chemistry·Dawei Yue, Richard C Larock